Fondaparinux Subcutaneous and Renal disease
Result of checking the interaction of drug Fondaparinux Subcutaneous and disease Renal disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Some factor Xa inhibitors such as rivaroxaban and fondaparinux should be avoided in patients with CrCl <30 mL/min. Observe closely and promptly evaluate any signs or symptoms of blood loss in patients with CrCl 30 to 50 mL/min. Treatment should be discontinued in patients who develop acute renal failure while on treatment with these drugs.
Generic Name: fondaparinux
Brand Name: Arixtra, Arixtra 5 mg/dose, Arixtra 75 mg/dose, Arixtra 10 mg/dose
Synonyms: Fondaparinux
Fondaparinux Subcutaneous - choroba nerek 
Fondaparinux Subcutaneous - doença renal 
Fondaparinux Subcutaneous - penyakit buah pinggang 
Fondaparinux Subcutaneous - penyakit ginjal 
Fondaparinux Subcutaneous - malattia renale 
Fondaparinux Subcutaneous - maladie rénale 
Fondaparinux Subcutaneous - Nierenkrankheit 
Fondaparinux Subcutaneous - enfermedad renal 
Fondaparinux Subcutaneous - почечная болезнь 
Fondaparinux Subcutaneous - böbrek hastalığı 
Fondaparinux Subcutaneous - امراض الكلى 
Fondaparinux Subcutaneous - 肾脏疾病